Watermark
  Back to Search Results

BGB-B2033-101

Recruiting

A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Request Information

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-B2033-101

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT06427941

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2025

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20242917

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Locations

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents